Related Experiment Videos
Experience with polytetrafluoroethylene grafts in children with cyanotic congenital heart disease
Insights
Polytetrafluoroethylene (PTFE) Gore-Tex shunts provided good palliation for children with severe cyanotic congenital heart defects. However, close follow-up is essential due to potential complications like thrombosis and infection.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomaterials in Medicine
Background:
- Severe cyanotic congenital heart defects require surgical palliation.
- Systemic-pulmonary shunts are a common palliative strategy.
- Polytetrafluoroethylene (PTFE) grafts are utilized for shunt construction.
Purpose of the Study:
- To evaluate the survival and event-free rates of PTFE shunts in pediatric patients.
- To assess graft patency and identify complications associated with PTFE shunts.
Main Methods:
- Retrospective actuarial analysis of 47 PTFE shunts in 42 children.
- Study period: April 1981 to March 1983, with 27-month follow-up.
- Data analyzed in 3-month intervals.
Main Results:
- Estimated two-year patient survival: 86%.
- Estimated two-year event-free rate: 57.2%.
- Graft patency rate: 89% (42/47 grafts).
Conclusions:
- PTFE grafts offer effective palliation for severe cyanotic congenital heart defects.
- Complications include thrombosis, infection, heart failure, shunt stenosis, and pulmonary artery deformity.
- Mandatory close follow-up is required to manage complications and improve outcomes.
Abstract:
Survival and event-free rates of 47 polytetrafluoroethylene (PTFE) (Gore-Tex) shunts for severe cyanotic congenital heart defects were studied in 42 children from April, 1981, to March, 1983. Retrospective actuarial analysis was conducted over the 27 months of the study in 3-month intervals of the follow-up. The estimated actuarial patient survival at two years was 86% with an estimated actuarial event-free rate of 57.2%. The grafts were found to be patent in 89% (42/47) of the grafts. Complications associated with PTFE grafts were thrombosis, infections, heart failure, shunt stenosis, and deformity of the pulmonary arteries. Polytetrafluoroethylene grafts for systemic-pulmonary shunts offer good palliation, but the frequency of complications indicates that close follow-up is mandatory to avoid or treat serious sequelae of the complications.